30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Aesculap Implant Systems received FDA approval to market the activL® Artificial Disc for treatment of 1-level lumbar degenerative disc disease. activL features a mobile ultra high molecular weight polyethylene core, supporting controlled translational and rotational movement, and a range of footprints and heights, including a low 8.5 mm construct. (Aesculap Implant Systems LLC, 6/15/15)